Tech Company Financing Transactions
Olaris Funding Round
LabCorp participated in a Series B funding round for Olaris. The round was announced by the company on 4/11/2025.
Transaction Overview
Company Name
Announced On
4/11/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
Labcorp's investment and strategic collaboration will help accelerate the expansion of myOLARIS� diagnostic products which use NMR detection of metabolites to transform how diseases are diagnosed and treated.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
175 Crossing Blvd
Framingham, MA 01702
USA
Framingham, MA 01702
USA
Phone
Undisclosed
Website
Email Address
Overview
Olaris is revolutionizing how diseases are diagnosed and treated by combining metabolomics and machine learning to develop precision diagnostics for the entire patient journey. Patients deserve to have confidence that they have the right diagnosis and that they are on the most optimal treatment path. Olaris precision diagnostics will improve patient outcomes, limit unnecessary side effects and reduce waste in the healthcare system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elizabeth O'Day
Browse more venture capital transactions:
Prev: 4/11/2025: Okeiro venture capital transaction
Next: 4/11/2025: Jobandtalent venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs